These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30737806)

  • 1. Pharmacokinetics of the novel COX-2 selective inhibitor vitacoxib in cats: The effects of feeding and dose.
    Wang J; Gong X; Xue J; Zhang S; Li J; Cao X
    J Vet Pharmacol Ther; 2019 May; 42(3):294-299. PubMed ID: 30737806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vitacoxib in rabbits after intravenous and oral administration.
    Wang J; Xue J; Zhang L; Zhang S; Li J; Cao X
    J Vet Pharmacol Ther; 2019 May; 42(3):368-371. PubMed ID: 30761557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses.
    Wang J; Xue J; Kong J; Li J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2018 Dec; 41(6):843-847. PubMed ID: 30076623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of three formulations of vitacoxib in horses.
    Wang J; Qiu J; Xiao H; Gong X; Sun P; Li J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2020 Jul; 43(4):364-368. PubMed ID: 32162352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of vitacoxib, a novel COX-2 inhibitor, in equine plasma using UPLC-MS/MS detection: Development and validation of new methodology.
    Wang J; Zhao T; Kong J; Peng H; Lv P; Li J; Cao X; Zhang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():270-274. PubMed ID: 28759842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.
    Wang J; Schneider BK; Sun P; Gong X; Qiu J; Li J; Seo YJ; Mochel JP; Cao X
    J Vet Pharmacol Ther; 2019 Sep; 42(5):530-540. PubMed ID: 31369157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.
    Kvaternick V; Pollmeier M; Fischer J; Hanson PD
    J Vet Pharmacol Ther; 2007 Jun; 30(3):208-17. PubMed ID: 17472652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety assessment of vitacoxib: 180-day chronic oral toxicity studies.
    Wang J; Zhao T; Tang S; Zhang S; Lv P; Li J; Cao X
    Regul Toxicol Pharmacol; 2018 Jun; 95():244-249. PubMed ID: 29601910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of feeding on the pharmacokinetics of oral minocycline in healthy adult horses.
    Echeverria KO; Lascola KM; Giguère S; Foreman JH
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e53-e56. PubMed ID: 28891075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats.
    Wang J; Schneider BK; Xiao H; Qiu J; Gong X; Seo YJ; Li J; Mochel JP; Cao X
    Front Vet Sci; 2020; 7():554033. PubMed ID: 33102567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety assessment of vitacoxib: Acute and 90-day sub-chronic oral toxicity studies.
    Wang J; Sun F; Tang S; Zhang S; Lv P; Li J; Cao X
    Regul Toxicol Pharmacol; 2017 Jun; 86():49-58. PubMed ID: 28238853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced plasma concentration by selective deuteration of rofecoxib in rats.
    Schneider F; Hillgenberg M; Koytchev R; Alken RG
    Arzneimittelforschung; 2006; 56(4):295-300. PubMed ID: 16724516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs.
    Kim TW; Lebkowska-Wieruszewska B; Owen H; Yun HI; Kowalski CJ; Giorgi M
    Vet J; 2014 Apr; 200(1):77-81. PubMed ID: 24461644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tildipirosin in beagle dogs.
    Wang J; Zhao T; Sun X; Liu Y; Zhu J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e49-e52. PubMed ID: 28892155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetic profile of cimicoxib in dogs and cats after IV administration.
    Schneider M; Dron F; Cuinet E; Woehrlé F
    Vet J; 2021 Apr; 270():105625. PubMed ID: 33641805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a novel antiangiogenic agent KR-31831 in rats.
    Kim SJ; Lee HI; Ji HY; Moon Y; Paek IB; Lee S; Yi KY; Yoo SD; Lee HS
    Biopharm Drug Dispos; 2005 Jan; 26(1):21-6. PubMed ID: 15578734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.